Therapeutic compositions, combinations, and methods of use
Abstract:
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1; that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
Public/Granted literature
Information query
Patent Agency Ranking
0/0